{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:36:42Z","timestamp":1793828202701,"version":"4.6.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T00:00:00Z","timestamp":1739750400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Ischaemic cardiac arrest has poor survival. In an earlier animal study, we have shown that levosimendan increases the return of spontaneous circulation and survival compared with placebo. However, the impact of levosimendan on central cardiovascular variables and gas exchange during resuscitation in ischaemic cardiac arrest is unknown.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To evaluate levosimendan's dose\u2013response effect on central cardiovascular variables and gas exchange in an established swine cardiac arrest model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN<\/jats:title>\n            <jats:p>A large animal study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING<\/jats:title>\n            <jats:p>Animal study with Swedish landrace pigs at Karolinska Institutet, Sweden.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTION<\/jats:title>\n            <jats:p>Ten swine underwent induced acute myocardial infarction and ventricular fibrillation. Levosimendan (62.5\u200a\u03bcg\u200akg<jats:sup>\u22121<\/jats:sup>) was administered during resuscitation, and immediate outcomes were compared with low dose levosimendan (12\u200a\u03bcg\u200akg<jats:sup>\u22121<\/jats:sup>, <jats:italic toggle=\"yes\">n<\/jats:italic>\u200a\n                                 <jats:italic toggle=\"yes\">=<\/jats:italic>\u200a12) or placebo (<jats:italic toggle=\"yes\">n<\/jats:italic>\u200a\n                                 <jats:italic toggle=\"yes\">=<\/jats:italic>\u200a12) from earlier experiments using the same model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MAIN OUTCOME MEASURES<\/jats:title>\n            <jats:p>Haemodynamic and gas exchange variables during resuscitation. Time to and proportion of return to spontaneous circulation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>High-dose levosimendan improved gas exchange, with better arterial O<jats:sub>2<\/jats:sub> and CO<jats:sub>2<\/jats:sub> levels (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a0.01), reduced systolic pulmonary arterial pressure, central venous pressure and vasopressor support with adrenaline after return to spontaneous circulation compared with low dose and placebo (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.01). All animals in both levosimendan groups achieved return to spontaneous circulation compared with 67% in the placebo group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.02). Median [IQR] time to return of spontaneous circulation was 15\u200amin [12 to 18] for high dose 17\u200amin [15 to 26] for low dose compared with 23\u200amin [15 to 60] for placebo (<jats:italic toggle=\"yes\">P<\/jats:italic>\u200a=\u200a0.08).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS<\/jats:title>\n            <jats:p>Levosimendan enhances key resuscitation outcomes in the immediate period of ischaemic cardiac arrest, promoting its potential as an effective pharmacological intervention. With an apparent dose-dependent reduction in right ventricular afterload and subsequent improvement in gas exchange, we cautiously propose that levosimendan-induced pulmonary vasodilation alleviates right heart strain and improves interventricular dependency, thereby enhancing the likelihood of return of spontaneous circulation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/eja.0000000000002144","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:00:32Z","timestamp":1739862032000},"page":"518-526","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Levosimendan improves central haemodynamic status and gas exchange in a model of ischaemic cardiac arrest"],"prefix":"10.1097","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7844-9751","authenticated-orcid":false,"given":"Susanne","family":"Rysz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Al-Saadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Campoccia Jalde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Lundberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Jonsson Fagerlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Dj\u00e4rv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,17]]},"reference":[{"key":"R1-20250514","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.hlc.2018.08.026","article-title":"Epidemiology of sudden cardiac death: global and regional perspectives","volume":"28","author":"Wong","year":"2019","journal-title":"Heart Lung Circ"},{"key":"R2-20250514","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.resuscitation.2019.04.008","article-title":"Vasopressors during adult cardiac arrest: a systematic review and meta-analysis","volume":"139","author":"Holmberg","year":"2019","journal-title":"Resuscitation"},{"key":"R3-20250514","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/ehjcvp\/pvv047","article-title":"Drug therapy in cardiac arrest: a review of the literature","volume":"2","author":"Lundin","year":"2016","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"R4-20250514","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.resuscitation.2021.02.003","article-title":"European Resuscitation Council Guidelines 2021: executive summary","volume":"161","author":"Perkins","year":"2021","journal-title":"Resuscitation"},{"key":"R5-20250514","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ejphar.2014.06.024","article-title":"The role of levosimendan in cardiopulmonary resuscitation","volume":"740","author":"Varvarousi","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"R6-20250514","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2011.07.022","article-title":"Levosimendan: molecular mechanisms and clinical implications: consensus of experts on the mechanisms of action of levosimendan","volume":"159","author":"Papp","year":"2012","journal-title":"Int J Cardiol"},{"key":"R7-20250514","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1527-3466.2005.tb00158.x","article-title":"Pharmacological mechanisms contributing to the clinical efficacy of levosimendan","volume":"23","author":"Papp","year":"2005","journal-title":"Cardiovasc Drug Rev"},{"key":"R8-20250514","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.jacc.2005.11.041","article-title":"Levosimendan improves cardiopulmonary resuscitation and survival by KATPChannel activation","volume":"47","author":"Cammarata","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R9-20250514","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.CCM.0000156241.55872.15","article-title":"Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction\u2217","volume":"33","author":"Huang","year":"2005","journal-title":"Crit Care Med"},{"key":"R10-20250514","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/00003246-200111000-00022","article-title":"Effects of levosimendan, a novel inotropic calcium-sensitizing drug, in experimental septic shock","volume":"29","author":"Oldner","year":"2001","journal-title":"Crit Care Med"},{"key":"R11-20250514","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12871-017-0309-3","article-title":"Supplement of levosimendan to epinephrine improves initial resuscitation outcomes from asphyxial cardiac arrest","volume":"17","author":"Wu","year":"2017","journal-title":"BMC Anesthesiol"},{"key":"R12-20250514","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.resuscitation.2020.02.032","article-title":"The effect of levosimendan on survival and cardiac performance in an ischemic cardiac arrest model - a blinded randomized placebo-controlled study in swine","volume":"150","author":"Rysz","year":"2020","journal-title":"Resuscitation"},{"key":"R13-20250514","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1053\/j.jvca.2013.07.018","article-title":"Useful supplement to the best practice of using levosimendan in cardiac surgery patients: 2.5-mg intravenous bolus for cardiopulmonary resuscitation during perioperative cardiac arrest","volume":"27","author":"Carev","year":"2013","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"R14-20250514","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"R15-20250514","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1399-6576.2007.01383.x","article-title":"Levosimendan improves the initial outcome of cardiopulmonary resuscitation in a swine model of cardiac arrest","volume":"51","author":"Koudouna","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R16-20250514","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.resuscitation.2005.06.007","article-title":"Resuscitation from adrenaline resistant electro-mechanical dissociation facilitated by levosimendan in a young man with idiopathic dilated cardiomyopathy","volume":"68","author":"Tsagalou","year":"2006","journal-title":"Resuscitation"},{"key":"R17-20250514","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.ajem.2008.05.004","article-title":"Combination pharmacotherapy in the treatment of experimental cardiac arrest","volume":"27","author":"Xanthos","year":"2009","journal-title":"Am J Emerg Med"},{"key":"R18-20250514","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.amjcard.2006.06.052","article-title":"Effects of levosimendan on right ventricular function in patients with advanced heart failure","volume":"98","author":"Parissis","year":"2006","journal-title":"Am J Cardiol"},{"key":"R19-20250514","doi-asserted-by":"crossref","first-page":"e0233176","DOI":"10.1371\/journal.pone.0233176","article-title":"Levosimendan reduces segmental pulmonary vascular resistance in isolated perfused rat lungs and relaxes human pulmonary vessels","volume":"15","author":"Rieg","year":"2020","journal-title":"PLoS One"},{"key":"R20-20250514","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/FJC.0b013e31824938f0","article-title":"Levosimendan attenuates hypoxia-induced pulmonary hypertension in a porcine model","volume":"59","author":"Wiklund","year":"2012","journal-title":"J Cardiovasc Pharmacol"},{"key":"R21-20250514","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1399-6576.1998.tb05077.x","article-title":"Systemic oxygen uptake during experimental closed-chest cardiopulmonary resuscitation using air or pure oxygen ventilation","volume":"42","author":"Rubertsson","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"R22-20250514","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ajem.2022.08.058","article-title":"The difference between arterial pCO2 and etCO2 after cardiac arrest - outcome predictor or marker of unfavorable resuscitation circumstances?","volume":"61","author":"Mueller","year":"2022","journal-title":"Am J Emerg Med"},{"key":"R23-20250514","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40635-019-0289-3","article-title":"Correction to: a case of intracoronary and endovenous levosimendan as a rescue therapy for refractory cardiac arrest","volume":"8","author":"Ferro","year":"2020","journal-title":"Intensive Care Med Exp"},{"key":"R24-20250514","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/01.fjc.0000175435.41541.6f","article-title":"Hemodynamic effect of intracoronary administration of levosimendan in the anesthetized pig","volume":"46","author":"Grossini","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"R25-20250514","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.ejheart.2007.10.002","article-title":"Effects of levosimendan on coronary artery flow and cardiac performance in patients with advanced heart failure","volume":"9","author":"Ikonomidis","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"R26-20250514","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/01.CIR.0000159252.82444.22","article-title":"Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake","volume":"111","author":"Michaels","year":"2005","journal-title":"Circulation"}],"container-title":["European Journal of Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000002144","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T11:00:15Z","timestamp":1747220415000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/EJA.0000000000002144"}},"subtitle":["A large animal study"],"short-title":[],"issued":{"date-parts":[[2025,2,17]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/eja.0000000000002144","relation":{},"ISSN":["0265-0215","1365-2346"],"issn-type":[{"value":"0265-0215","type":"print"},{"value":"1365-2346","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,17]]}}}